Bronchopulmonary dysplasia, in a third of preemies, 87% reduced risk for just 1 ng higher Vitamin D level

Created October 2024

Nonlinear relationship between vitamin D status on admission and bronchopulmonary dysplasia in preterm infants

Pediatr Res. 2024 Oct 9. doi: 10.1038/s41390-024-03621-6   PDF behind paywall

Shuo Wang 1, Mingjie Wang 1, Xiaohe Yu 1, Chuanding Cao 1, Ying Ding 1, Mei Lv 1, Yang Liu 1, Meiyan Chu 1, Keren Fang 1, Zhengchang Liao 2, Shaojie Yue 3

Background: This research will explore non-linear relationship between vitamin D status on admission and bronchopulmonary dysplasia (BPD) in preterm infants.

Methods: Data were retrospectively collected on preterm infants ≤32 weeks gestation and ≥28 weeks gestation hospitalized in our hospital between Jan. 2019 and Jul. 2022, which were classified into BPD and non-BPD groups according to BPD diagnostic criteria. Independent influences between the two groups were staged using comparison of differences between groups, univariate analysis, multivariate analysis, smoothed curve fitting, and threshold effect staging.

Results: 255 preterm infants were enrolled in this research, including 135 males and 120 females, with a mean gestational age of 30.59 ± 0.86 weeks. Vitamin D status on admission was an independent protective factor for BPD in preterm infants, with a 6% reduction in the probability of BPD for every 1 ng/ml increase in vitamin D status on admission (p = 0.036).

There was also a non-linear relationship, with each 1 ng/ml increase in vitamin D status on admission being associated with an 87% reduction in the incidence of BPD when vitamin D status was <12.82 ng/ml (p = 0.010).

Conclusion: Vitamin D status on admission and BPD are non-linearly in preterm infants at 28-32 weeks gestation.

Impact statement: Analyzing the relationship between vitamin D status on admission and BPD. A nonlinear relationship and turning point between vitamin D status on admission and BPD was derived by curve fitting and threshold effect. We provide a new reference point for vitamin D supplementation for the prevention of neonatal BPD and to avoid ineffective overmedication.

34 References

  1. Northway, W. H. Jr, Rosan, R. C. & Porter, D. Y. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N. Engl. J. Med. 276, 357–368 (1967). - DOI - PubMed

  2. Jobe, A. H. & Bancalari, E. Bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 163, 1723–1729 (2001). - DOI - PubMed

  3. Stoll, B. J. et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 126, 443–456 (2010). - DOI - PubMed

  4. Stoll, B. J. et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 314, 1039–1051 (2015). - DOI - PubMed - PMC

  5. Horbar, J. D. et al. Variation in performance of neonatal intensive care units in the United States. JAMA Pediatr. 171, e164396 (2017). - DOI - PubMed

  6. Li, P. P. & Zhao, W. Definition evolution and epidemiological characteristics of bronchopulmonary dysplasia in premature infants. Chin. J. Neonatol. 35, 385–388 (2020).

  7. Jensen, E. A. et al. Severity of bronchopulmonary dysplasia among very preterm infants in the United States. Pediatrics 148, e2020030007 (2021). - DOI - PubMed

  8. Davidson, L. M. & Berkelhamer, S. K. Bronchopulmonary dysplasia: chronic lung disease of infancy and long-term pulmonary outcomes. J. Clin. Med. 6, 4 (2017). - DOI - PubMed - PMC

  9. Bhandari, A. & Panitch, H. B. Pulmonary outcomes in bronchopulmonary dysplasia. Semin. Perinatol. 30, 219–226 (2006). - DOI - PubMed

  10. Hartling, L., Liang, Y. & Lacaze-Masmonteil, T. Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis. Arch. Dis. Child Fetal Neonatal Ed. 97, F8–F17 (2012). - DOI - PubMed

  11. Bose, C. et al. Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation. Pediatrics 124, e450–e458 (2009). - DOI - PubMed

  12. Leary, S., Das, P., Ponnalagu, D., Singh, H. & Bhandari, V. Genetic strain and sex differences in a hyperoxia-induced mouse model of varying severity of bronchopulmonary dysplasia. Am. J. Pathol. 189, 999–1014 (2019). - DOI - PubMed - PMC

  13. Antonucci, R., Contu, P., Porcella, A., Atzeni, C. & Chiappe, S. Intrauterine smoke exposure: a new risk factor for bronchopulmonary dysplasia? J. Perinat. Med. 32, 272–277 (2004). - DOI - PubMed

  14. Ahmad, S. et al. Vitamin D and its therapeutic relevance in pulmonary diseases. J. Nutr. Biochem. 90, 108571 (2021). - DOI - PubMed

  15. Brehm, J. M. et al. Vitamin D insufficiency and severe asthma exacerbations in Puerto Rican children. Am. J. Respir. Crit. Care Med. 186, 140–146 (2012). - DOI - PubMed - PMC

  16. Mao, X. et al. Vitamin D and IL-10 deficiency in preterm neonates with bronchopulmonary dysplasia. Front. Pediatr. 6, 246 (2018). - DOI - PubMed - PMC

  17. Ge, H. et al. The association of vitamin D and vitamin E levels at birth with bronchopulmonary dysplasia in preterm infants. Pediatr. Pulmonol. 56, 2108–2113 (2021). - DOI - PubMed

  18. Joung, K. E. et al. Vitamin D and bronchopulmonary dysplasia in preterm infants. J. Perinatol. 36, 878–882 (2016). - DOI - PubMed - PMC

  19. Tsuprykov, O. et al. Opposite correlation of 25-hydroxy-vitamin D- and 1,25-dihydroxy-vitamin D-metabolites with gestational age, bone- and lipid-biomarkers in pregnant women. Sci. Rep. 11, 1923 (2021). - DOI - PubMed - PMC

  20. Çetinkaya, M. et al. Maternal/neonatal vitamin D deficiency: a risk factor for bronchopulmonary dysplasia in preterms? J. Perinatol. 35, 813–817 (2015). - DOI - PubMed

  21. Ali, Z., Schmidt, P., Dodd, J. & Jeppesen, D. L. Predictors of bronchopulmonary dysplasia and pulmonary hypertension in newborn children. Dan. Med. J. 60, A4688 (2013). - PubMed

  22. Yin, J. et al. Mechanical ventilation characteristics and their prediction performance for the risk of moderate and severe bronchopulmonary dysplasia in infants with gestational age <30 weeks and birth weight <1500 g. Front. Pediatr. 10, 993167 (2022). - DOI - PubMed - PMC

  23. Park, H. W. et al. Association between vitamin D level and bronchopulmonary dysplasia: a systematic review and meta-analysis. PLoS ONE 15, e0235332 (2020). - DOI - PubMed - PMC

  24. Kalikkot Thekkeveedu, R., Guaman, M. C. & Shivanna, B. Bronchopulmonary dysplasia: a review of pathogenesis and pathophysiology. Respir. Med. 132, 170–177 (2017). - DOI - PubMed

  25. Sakurai, R. et al. 1alpha,25(OH)2D3 and its 3-epimer promote rat lung alveolar epithelial-mesenchymal interactions and inhibit lipofibroblast apoptosis. Am. J. Physiol. Lung Cell Mol. Physiol. 297, L496–L505 (2009). - DOI - PubMed - PMC

  26. Hu, J. et al. Vitamin D ameliorates apoptosis and inflammation by targeting the mitochondrial and MEK1/2-ERK1/2 pathways in hyperoxia-induced bronchopulmonary dysplasia. J. Inflamm. Res. 15, 4891–4906 (2022). - DOI - PubMed - PMC

  27. Mandell, E. et al. Antenatal endotoxin disrupts lung vitamin D receptor and 25-hydroxyvitamin D 1α-hydroxylase expression in the developing rat. Am. J. Physiol. Lung Cell Mol. Physiol. 309, L1018–L1026 (2015). - DOI - PubMed - PMC

  28. Weisman, Y. Maternal, fetal and neonatal vitamin D and calcium metabolism during pregnancy and lactation. Endocr. Dev. 6, 34–49 (2003). - DOI - PubMed

  29. McCarthy, R. A. et al. Vitamin D nutritional status in preterm infants and response to supplementation. Br. J. Nutr. 110, 156–163 (2013). - DOI - PubMed

  30. Burris, H. H. et al. Vitamin D status among preterm and full-term infants at birth. Pediatr. Res. 75, 75–80 (2014). - DOI - PubMed

  31. Misra, M., Pacaud, D., Petryk, A., Collett-Solberg, P. F. & Kappy, M. Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 122, 398–417 (2008). - DOI - PubMed

  32. Hollis, B. W., Johnson, D., Hulsey, T. C., Ebeling, M. & Wagner, C. L. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J. Bone Min. Res. 26, 2341–2357 (2011). - DOI

  33. Wagner, C. L. et al. A randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina. Am. J. Obstet. Gynecol. 208, 137.e1–13 (2013). - DOI - PubMed

VitaminDWiki - 3X reduction in preemie Bronchopulmonary Dysplasia if add tiny amount of Vitamin D – meta-analysis June 2024

VitaminDWiki - Preterm births reduced by Vitamin D - many studies

VitaminDWiki - Preterm birth decreased by Omega-3, etc. - many studies

Tags: Breathing Infant-Child